SFTPD and ovarian adenocarcinoma: Downregulated SP-D expression has been reported in the lung, breast, and gastric cancers as compared to the healthy controls, whereas high transcriptional and protein expression of SP-D is found in the ovarian adenocarcinoma (19, 38).